Skip to content
Upperton Pharma Solutions logo — Your Integrated CDMO Specialist. Driven by experts, led by s...

Upperton Pharma Solutions

Your Integrated CDMO Specialist. Driven by experts, led by science.

Founded 1999 United Kingdom Nottingham, United Kingdom 123 employees Private Equity Biotechnology, Industrial +1

General Information

Company Name Upperton Pharma Solutions
Founded Year 1999
Location United Kingdom Nottingham, United Kingdom
Employees 123
Industries Biotechnology, Industrial, Pharmaceutical
Funding Stage Private Equity
Business Model B2B, B2B2B
Revenue Model Service Fee, Project Based, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Upperton Pharma Solutions. To contact Upperton Pharma Solutions, visit upperton.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Upperton Pharma Solutions compare?

A PDF of Upperton Pharma Solutions and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Upperton Pharma Solutions soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Upperton Pharma Solutions

Upperton Pharma Solutions, established in 1999, is a specialist CDMO (contract development and manufacturing organisation) headquartered in the United Kingdom. The company serves the biotechnology, industrial, and pharmaceutical industries with expertise in formulation and dosage form development, as well as clinical trial manufacturing services.

Recognized for its slogan, "Your Integrated CDMO Specialist. Driven by experts, led by science.", Upperton provides a comprehensive development service from early feasibility studies to clinical trial manufacturing. The company excels particularly in pharmaceutical spray drying, a leading technology known for its versatility.

With an extensive, multinational client base, Upperton prides itself on a flexible, client-focused approach and scientific excellence. Their last notable financial activity was a Private Equity Round on April 21, 2022, with backing from Inflexion Partners, indicating strong investor confidence in their growth and capabilities.

Business keywords: Contract Development and Manufacturing Organization (CDMO), Pharmaceutical Formulation Development, Dosage Form Development, Clinical Trial Manufacturing, Spray Drying Technology, Freeze Drying, Solubility Enhancement, Bioavailability Enhancement, Particle Engineering, GMP Manufacturing, Pulmonary Delivery, Nasal Delivery, Oral Dosage Forms, Biologic Stabilisation, Modified Release Technology

Services & Products

Integrated CDMO Services
Formulation Development
Analytical Development & Validation
Phase I - II Clinical Supply
Process Scale-Up for Phase III
Sterile Fill/Finish Manufacturing

Target Customers

Pharmaceutical Companies Biotech Firms Therapeutic Research Organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Inflexion Partners
21 Apr 2022

Upperton Pharma Solutions Alternatives & Competitors

View All Alternatives
Upperton Pharma Solutions vs
Catalent
Catalent United States

more products. better treatments. reliably supplied. ™

Post-IPO Debt
12614 employees
Biotechnology, Manufacturing
Upperton Pharma Solutions vs

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)

Venture round
20 employees
Biotechnology, Pharmaceutical
Upperton Pharma Solutions vs
Nanoform
Nanoform Finland

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical...

Grant
Biotechnology, Pharmaceutical

FAQ About Upperton Pharma Solutions

Your Integrated CDMO Specialist. Driven by experts, led by science.
Upperton Pharma Solutions was founded in 1999.
Upperton Pharma Solutions is headquartered in Nottingham, United Kingdom.
Upperton Pharma Solutions operates in Biotechnology, Industrial and Pharmaceutical. Its work centres on Contract Development and Manufacturing Organization (CDMO), Pharmaceutical Formulation Development, Dosage Form Development and Clinical Trial Manufacturing. Its customers include Pharmaceutical Companies, Biotech Firms and Therapeutic Research Organizations.
Upperton Pharma Solutions has a B2B and B2B2B business model. Its revenue comes from Service Fee, Project Based and Usage Based.
Upperton Pharma Solutions has approximately 123 employees.
Upperton Pharma Solutions has completed 1 funding round. The latest funding stage is Private Equity.
Upperton Pharma Solutions offers: Integrated CDMO Services, Formulation Development, Analytical Development & Validation, Phase I - II Clinical Supply, Process Scale-Up for Phase III, Sterile Fill/Finish Manufacturing.
Top alternatives and competitors to Upperton Pharma Solutions include Catalent, CritiTech Particle Engineering Solutions, Nanoform, LTS Lohmann Therapie-Systeme AG, AGC Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Upperton Pharma Solutions and Catalent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Upperton Pharma Solutions, https://bouncewatch.com/company/upperton-pharma-solutions, updated 12 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout